Výsledky vyhledávání

Akademický článek

CD155/PVR determines acute myeloid leukemia targeting by Delta One T cells.

Autor: Mensurado S; Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal., Condeço C; Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal., Sánchez-Martínez D; Josep Carreras Leukaemia Research Institute, Department of Biomedicine, School of Medicine, University of Barcelona, Barcelona, Spain.; Red Española de Terapias Avanzadas, Instituto de Salud Carlos III, Redes de Investigación Cooperativa Orientadas a Resultados en Salud (RD21/0017/0029), Madrid, Spain.; Aragon Health Research Institute, Centro de Investigación Biomédica en Red en Enfermedades Infecciosas, Instituto de Salud Carlos III, Zaragoza, Spain.; Aragon I+D Foundation, Zaragoza, Spain., Shirley S; Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal., Coelho RML; Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal., Tirado N; Josep Carreras Leukaemia Research Institute, Department of Biomedicine, School of Medicine, University of Barcelona, Barcelona, Spain.; Red Española de Terapias Avanzadas, Instituto de Salud Carlos III, Redes de Investigación Cooperativa Orientadas a Resultados en Salud (RD21/0017/0029), Madrid, Spain., Vinyoles M; Josep Carreras Leukaemia Research Institute, Department of Biomedicine, School of Medicine, University of Barcelona, Barcelona, Spain.; Red Española de Terapias Avanzadas, Instituto de Salud Carlos III, Redes de Investigación Cooperativa Orientadas a Resultados en Salud (RD21/0017/0029), Madrid, Spain., Blanco-Domínguez R; Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal., Barros L; Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal., Galvão B; Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal., Custódio N; Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal., Gomes da Silva M; Instituto Português de Oncologia Francisco Gentil, Lisbon, Portugal., Menéndez P; Josep Carreras Leukaemia Research Institute, Department of Biomedicine, School of Medicine, University of Barcelona, Barcelona, Spain.; Red Española de Terapias Avanzadas, Instituto de Salud Carlos III, Redes de Investigación Cooperativa Orientadas a Resultados en Salud (RD21/0017/0029), Madrid, Spain.; Centro de Investigación Biomédica en Red-Oncología, Instituto de Salud Carlos III, Barcelona, Spain.; Institució Catalana de Recerca i Estudis Avançats, Barcelona, Spain., Silva-Santos B; Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal.

Publikováno v: Blood [Blood] 2024 Apr 11; Vol. 143 (15), pp. 1488-1495.

Zobrazit plný text záznamu

Akademický článek

Short-chain fatty acids inhibit the activation of T lymphocytes and myeloid cells and induce innate immune tolerance.

Autor: Porbahaie M; Cell Biology and Immunology, Wageningen University & Research, De Elst 1, 6700 HB Wageningen, the Netherlands., Hummel A; Cell Biology and Immunology, Wageningen University & Research, De Elst 1, 6700 HB Wageningen, the Netherlands., Saouadogo H; Cell Biology and Immunology, Wageningen University & Research, De Elst 1, 6700 HB Wageningen, the Netherlands., Coelho RML; Cell Biology and Immunology, Wageningen University & Research, De Elst 1, 6700 HB Wageningen, the Netherlands., Savelkoul HFJ; Cell Biology and Immunology, Wageningen University & Research, De Elst 1, 6700 HB Wageningen, the Netherlands., Teodorowicz M; Cell Biology and Immunology, Wageningen University & Research, De Elst 1, 6700 HB Wageningen, the Netherlands., van Neerven RJJ; Cell Biology and Immunology, Wageningen University & Research, De Elst 1, 6700 HB Wageningen, the Netherlands.; FrieslandCampina, Stationsplein 4, 3818 LE Amersfoort, the Netherlands.

Publikováno v: Beneficial microbes [Benef Microbes] 2023 Sep 01; Vol. 14 (4), pp. 401-419. Date of Electronic Publication: 2023 Sep 01.

Zobrazit plný text záznamu

Akademický článek

Cancer germline antigens and tumor-agnostic CD8 ⁺ T cell evasion.

Autor: Kortleve D; Laboratory of Tumor Immunology, Department of Medical Oncology, Erasmus MC Cancer Institute, Dr Molewaterplein 40, 3015, GD, Rotterdam, The Netherlands., Coelho RML; Laboratory of Tumor Immunology, Department of Medical Oncology, Erasmus MC Cancer Institute, Dr Molewaterplein 40, 3015, GD, Rotterdam, The Netherlands., Hammerl D; Laboratory of Tumor Immunology, Department of Medical Oncology, Erasmus MC Cancer Institute, Dr Molewaterplein 40, 3015, GD, Rotterdam, The Netherlands., Debets R; Laboratory of Tumor Immunology, Department of Medical Oncology, Erasmus MC Cancer Institute, Dr Molewaterplein 40, 3015, GD, Rotterdam, The Netherlands. Electronic address: j.debets@erasmusmc.nl.

Publikováno v: Trends in immunology [Trends Immunol] 2022 May; Vol. 43 (5), pp. 391-403. Date of Electronic Publication: 2022 Apr 10.

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání